Page 4 - Dan Eye News Today

Tech rout set to extend as investors fear rising inflation By Medha Singh Reuters (Reuters) -Wall Streets main indexes were set to open sharply lower on Tuesday, signaling another day of losses for technology-related stocks with lofty valuations on worries over inflation. The outperformers of 2020, Apple, Facebook Inc, Amazon.com Inc, Netflix Inc and Google-parent Alphabet Inc dropped between 1.7% and 2.8% in premarket trading, while Tesla Inc fell nearly 8%. Since the start of May, the 10-memb...

* Intel jumps on replacing CEO Bob Swan * Exxon rises on J.P. Morgan upgrade to “overweight” * Regeneron up as U.S. govt orders more COVID-19 therapy doses * Indexes: Dow and S&P down 0.13%, Nasdaq flat Jan 13 (Reuters) - Wall Street’s main indexes slipped on Wednesday as investors digested a recent run to record highs on hopes of new fiscal package and vaccine rollouts for the coronavirus-ravaged economy, while Intel shares jumped on executive change. The chipmaker said it would replace ...

4 Min Read NEW YORK (Reuters) - Wall Street’s benchmark S&P 500 index closed slightly higher on Wednesday with defensive sectors leading gains as investors waited for details of the next U.S. fiscal stimulus plan and Congress began President Donald Trump’s impeachment hearings. U.S. Treasury yields fell after rising for six straight sessions, giving a boost to rate-sensitive defensive sectors such as utilities and real estate, while economically sensitive cyclical sectors lagged. Intel Corp...

Wall Street trades flat as stimulus rally cools; Intel shines Expectations of a hefty COVID-19 relief package under the incoming Joe Biden administration and hopes of a rebound in corporate earnings this year have eclipsed concerns over signs that the labor market recovery has stalled amid rampant COVID-19 infections PTI | January 13, 2021 | Updated 22:07 IST Wall Streets main indexes slipped on Wednesday as investors digested a recent run to record highs on hopes of new fiscal package and vac...

* Regeneron up as U.S. govt orders more COVID-19 therapy doses

* Regeneron up as U.S. govt orders more COVID-19 therapy doses